Current Research Studies

APEC1621 MATCH

APEC1621

Condition(s): Brain Tumor, Ewing Sarcoma, Leukemia & Lymphoma, Medulloblastoma, Non-rhabdomyosarcoma Soft Tissue Sarcomas, Osteosarcoma, Other, Recurrent and/or Refractory, Rhabdomyosarcoma, Soft Tissue Sarcomas, Solid Tumor
Phase: II
Clinicaltrials.gov ID: NCT03526250

What is the goal of the study?

APEC1621 NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Katherine Tarlock
Study Team Member: Alvin Russell Ongoco, Alvinrussell.Ongoco@seattlechildrens.org

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.